Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Hurlin

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Human Molecular Genetics|September 16, 2017
HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasiaSara Ota, Zi-Qiang Zhou, Megan P Romero, et al.
Cell Death and Differentiation|August 12, 2017
Mnt modulates Myc-driven lymphomagenesisKirsteen J Campbell, Cassandra J Vandenberg, Natasha S Anstee, et al.
Human Molecular Genetics|July 31, 2012
Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type IIChia-Yi Shung, Sara Ota, Zi-Qiang Zhou, et al.
Plos One|April 16, 2011
Sequential and coordinated actions of c-Myc and N-Myc control appendicular skeletal developmentZi-Qiang Zhou, Chia-Yi Shung, Sara Ota, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2012
A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesisJason M Link, Sara Ota, Zi-Qiang Zhou, et al.
The EMBO Journal|September 13, 2003
Deletion of Mnt leads to disrupted cell cycle control and tumorigenesisPeter J Hurlin, Zi-Qiang Zhou, Kazuhito Toyo-oka, et al.
Cell Cycle (Georgetown, Tex.)|January 9, 2004
Evidence of mnt-myc antagonism revealed by mnt gene deletionPeter J Hurlin, Zi-Qiang Zhou, Kazuhito Toyo-Oka, et al.
Atherosclerosis|March 29, 2013
A repressor protein, Mnt, is a novel negative regulator of vascular smooth muscle cell hypertrophy by angiotensin II and neointimal hyperplasia by arterial injuryTakehiko Takayanagi, Akito Eguchi, Akira Takaguri, et al.
Oncogenesis|August 3, 2021
Correction: A novel role of MNT as a negative regulator of REL and the NF-κB pathwayJudit Liaño-Pons, M Carmen Lafita-Navarro, Lorena García-Gaipo, et al.
Oncogenesis|January 9, 2021
A novel role of MNT as a negative regulator of REL and the NF-κB pathwayJudit Liaño-Pons, M Carmen Lafita-Navarro, Lorena García-Gaipo, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Human Molecular Genetics|September 16, 2017
HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasiaSara Ota, Zi-Qiang Zhou, Megan P Romero, et al.
Cell Death and Differentiation|August 12, 2017
Mnt modulates Myc-driven lymphomagenesisKirsteen J Campbell, Cassandra J Vandenberg, Natasha S Anstee, et al.
Human Molecular Genetics|July 31, 2012
Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type IIChia-Yi Shung, Sara Ota, Zi-Qiang Zhou, et al.
Plos One|April 16, 2011
Sequential and coordinated actions of c-Myc and N-Myc control appendicular skeletal developmentZi-Qiang Zhou, Chia-Yi Shung, Sara Ota, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2012
A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesisJason M Link, Sara Ota, Zi-Qiang Zhou, et al.
The EMBO Journal|September 13, 2003
Deletion of Mnt leads to disrupted cell cycle control and tumorigenesisPeter J Hurlin, Zi-Qiang Zhou, Kazuhito Toyo-oka, et al.
Cell Cycle (Georgetown, Tex.)|January 9, 2004
Evidence of mnt-myc antagonism revealed by mnt gene deletionPeter J Hurlin, Zi-Qiang Zhou, Kazuhito Toyo-Oka, et al.
Atherosclerosis|March 29, 2013
A repressor protein, Mnt, is a novel negative regulator of vascular smooth muscle cell hypertrophy by angiotensin II and neointimal hyperplasia by arterial injuryTakehiko Takayanagi, Akito Eguchi, Akira Takaguri, et al.
Oncogenesis|August 3, 2021
Correction: A novel role of MNT as a negative regulator of REL and the NF-κB pathwayJudit Liaño-Pons, M Carmen Lafita-Navarro, Lorena García-Gaipo, et al.
Oncogenesis|January 9, 2021
A novel role of MNT as a negative regulator of REL and the NF-κB pathwayJudit Liaño-Pons, M Carmen Lafita-Navarro, Lorena García-Gaipo, et al.
Pageof 4